Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Hospital for Sick Children
Toronto, Ontario, Canada
- Mcgill University
Montreal, Quebec, Canada
- Stanford University
Palo Alto, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Washington University in St. Louis
St Louis, Missouri, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Mar 2022
- Primary completion
- 30 Sept 2025
- Completion
- 30 Sept 2025
- Last update posted
- 10 Dec 2025
- Registered enrollment
- 105
- Registry id
- NCT05161858
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.